Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Clasificación en acciones #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Precio por acción
$0.0048574
Capitalización bursátil
$126.82K
Cambio (1 día)
0.00%
Cambio (1 año)
-21.82%
País
IL
Comercio BioLineRx Ltd. (BLRX)

Categoría

Historial de rendimiento por dividendo de BioLineRx Ltd. (BLRX)
Rendimiento por dividendo (TTM) de BioLineRx Ltd. (símbolo bursátil: BLRX) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de BioLineRx Ltd. (BLRX) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE